艾塞那肽-话题@MedSci

#艾塞那肽#

36篇内容 | 1437人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1393609, encodeId=f791139360968, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Diabetes Obes Metab：艾塞那肽能诱导血管舒张因子增加并抑制肾素-血管紧张素系统, objectType=article, longId=99191, objectId=8f6d991917f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f6d991917f, replyNumber=0, likeNumber=34, createdTime=2017-05-21, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f6d991917f, moduleTitle=Diabetes Obes Metab：艾塞那肽能诱导血管舒张因子增加并抑制肾素-血管紧张素系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f6d991917f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393608, encodeId=f9031393608e0, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Diabetes Care：艾塞那肽与吡格列酮联合或可替代胰岛素治疗2型糖尿病（Qatar研究）, objectType=article, longId=87796, objectId=ceef8e796aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceef8e796aa, replyNumber=0, likeNumber=38, createdTime=2017-01-20, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceef8e796aa, moduleTitle=Diabetes Care：艾塞那肽与吡格列酮联合或可替代胰岛素治疗2型糖尿病（Qatar研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ceef8e796aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393607, encodeId=dd5e139360e13, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Circulation：院外心脏骤停患者急性运用艾塞那肽发挥神经保护作用, objectType=article, longId=82349, objectId=fc6c823498f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc6c823498f, replyNumber=0, likeNumber=26, createdTime=2016-11-15, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc6c823498f, moduleTitle=Circulation：院外心脏骤停患者急性运用艾塞那肽发挥神经保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc6c823498f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393606, encodeId=4f291393606d4, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=AHA 2016：降糖药艾塞那肽并不能改善院外心脏骤停患者的结局, objectType=article, longId=82319, objectId=65048231969, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65048231969, replyNumber=0, likeNumber=46, createdTime=2016-11-15, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65048231969, moduleTitle=AHA 2016：降糖药艾塞那肽并不能改善院外心脏骤停患者的结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65048231969)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393605, encodeId=ea3513936050f, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Diabetes Care：艾塞那肽对大脑活动和胰岛素分泌有啥影响？, objectType=article, longId=77884, objectId=5ee7e78844d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ee7e78844d, replyNumber=0, likeNumber=20, createdTime=2016-09-21, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ee7e78844d, moduleTitle=Diabetes Care：艾塞那肽对大脑活动和胰岛素分泌有啥影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ee7e78844d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393604, encodeId=14c3139360402, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=CDS 2015：艾塞那肽、胰岛素或吡格列酮对T2DM患者的影响（CONFIDENCE系列研究）, objectType=article, longId=60555, objectId=fdbf6055558, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdbf6055558, replyNumber=0, likeNumber=41, createdTime=2015-12-14, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdbf6055558, moduleTitle=CDS 2015：艾塞那肽、胰岛素或吡格列酮对T2DM患者的影响（CONFIDENCE系列研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdbf6055558)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393603, encodeId=eb761393603a0, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=J Intern Med：艾塞那肽、胰岛素和吡格列酮对新诊断为2型糖尿病的影响（CONFIDENCE研究）, objectType=article, longId=42372, objectId=cd25423e2c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd25423e2c5, replyNumber=0, likeNumber=37, createdTime=2014-11-12, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd25423e2c5, moduleTitle=J Intern Med：艾塞那肽、胰岛素和吡格列酮对新诊断为2型糖尿病的影响（CONFIDENCE研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd25423e2c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393602, encodeId=b93f1393602b4, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Lancet子刊：每周1次艾塞那肽与甘精胰岛素治疗2型糖尿病的对比研究（DURATION-3研究), objectType=article, longId=41434, objectId=3dd94143451, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dd94143451, replyNumber=0, likeNumber=37, createdTime=2014-10-20, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dd94143451, moduleTitle=Lancet子刊：每周1次艾塞那肽与甘精胰岛素治疗2型糖尿病的对比研究（DURATION-3研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dd94143451)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393601, encodeId=9364139360184, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=阿斯利康艾塞那肽注射笔Bydureon Pen获FDA批准, objectType=article, longId=31467, objectId=b8b63146efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8b63146efb, replyNumber=0, likeNumber=0, createdTime=2014-03-06, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8b63146efb, moduleTitle=阿斯利康艾塞那肽注射笔Bydureon Pen获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8b63146efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393600, encodeId=a1631393600bb, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=含吡格列酮和艾塞那肽的三联疗法优于传统逐步递增治疗, objectType=article, longId=20744, objectId=2e7920e44ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e7920e44ae, replyNumber=0, likeNumber=41, createdTime=2013-07-03, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e7920e44ae, moduleTitle=含吡格列酮和艾塞那肽的三联疗法优于传统逐步递增治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e7920e44ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393599, encodeId=5feb1393599f6, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Lancet：利拉鲁肽每和艾塞那肽均可改善2型糖尿病患者血糖控制, objectType=article, longId=10882, objectId=59371088215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59371088215, replyNumber=0, likeNumber=32, createdTime=2012-11-10, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59371088215, moduleTitle=Lancet：利拉鲁肽每和艾塞那肽均可改善2型糖尿病患者血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59371088215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393598, encodeId=932b139359889, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Lancet：艾塞那肽用于糖尿病二线治疗效果佳, objectType=article, longId=7216, objectId=4cdde21679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cdde21679, replyNumber=0, likeNumber=32, createdTime=2012-06-21, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cdde21679, moduleTitle=Lancet：艾塞那肽用于糖尿病二线治疗效果佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cdde21679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393597, encodeId=1abc139359e4e, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Lancet:二甲双胍追加艾塞那肽效果优于追加格列美脲, objectType=article, longId=7037, objectId=b300e037b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b300e037b3, replyNumber=0, likeNumber=40, createdTime=2012-06-16, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b300e037b3, moduleTitle=Lancet:二甲双胍追加艾塞那肽效果优于追加格列美脲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b300e037b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393596, encodeId=7d9213935968f, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=改善2型糖尿病肥胖患者胰岛素抵抗，减肥手术优于艾塞那肽, objectType=article, longId=5587, objectId=9810558e06, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9810558e06, replyNumber=0, likeNumber=36, createdTime=2012-04-22, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9810558e06, moduleTitle=改善2型糖尿病肥胖患者胰岛素抵抗，减肥手术优于艾塞那肽, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9810558e06)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393595, encodeId=fb5a139359533, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=Diabetes Care：艾塞那肽疗效安全性优于甘精胰岛素（IG）, objectType=article, longId=4172, objectId=fa1141e267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa1141e267, replyNumber=0, likeNumber=39, createdTime=2012-03-05, rootId=0, userName=紫砂壶, userId=04c22500137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa1141e267, moduleTitle=Diabetes Care：艾塞那肽疗效安全性优于甘精胰岛素（IG）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa1141e267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393594, encodeId=87da139359495, content=<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>, objectTitle=FDA批准缓释艾塞那肽获准抗II型糖尿病, objectType=article, longId=3892, objectId=4be238925f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4be238925f, replyNumber=0, likeNumber=32, createdTime=2012-02-08, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4be238925f, moduleTitle=FDA批准缓释艾塞那肽获准抗II型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4be238925f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

艾塞那肽

2020-05-29

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Diabetes Obes Metab：艾塞那肽能诱导血管舒张因子增加并抑制肾素-血管紧张素系统

2017-05-21

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Diabetes Care：艾塞那肽与吡格列酮联合或可替代胰岛素治疗2型糖尿病（Qatar研究）

2017-01-20

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Circulation：院外心脏骤停患者急性运用艾塞那肽发挥神经保护作用

2016-11-15

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

AHA 2016：降糖药艾塞那肽并不能改善院外心脏骤停患者的结局

2016-11-15

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Diabetes Care：艾塞那肽对大脑活动和胰岛素分泌有啥影响？

2016-09-21

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

CDS 2015：艾塞那肽、胰岛素或吡格列酮对T2DM患者的影响（CONFIDENCE系列研究）

2015-12-14

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

J Intern Med：艾塞那肽、胰岛素和吡格列酮对新诊断为2型糖尿病的影响（CONFIDENCE研究）

2014-11-12

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Lancet子刊：每周1次艾塞那肽与甘精胰岛素治疗2型糖尿病的对比研究（DURATION-3研究)

2014-10-20

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

阿斯利康艾塞那肽注射笔Bydureon Pen获FDA批准

2014-03-06

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

含吡格列酮和艾塞那肽的三联疗法优于传统逐步递增治疗

2013-07-03

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Lancet：利拉鲁肽每和艾塞那肽均可改善2型糖尿病患者血糖控制

2012-11-10

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Lancet：艾塞那肽用于糖尿病二线治疗效果佳

2012-06-21

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Lancet:二甲双胍追加艾塞那肽效果优于追加格列美脲

2012-06-16

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

改善2型糖尿病肥胖患者胰岛素抵抗，减肥手术优于艾塞那肽

2012-04-22

紫砂壶 (审核中...)

前往app查看评论内容

#艾塞那肽#

Diabetes Care：艾塞那肽疗效安全性优于甘精胰岛素（IG）

2012-03-05

智智灵药 (审核中...)

前往app查看评论内容

#艾塞那肽#

FDA批准缓释艾塞那肽获准抗II型糖尿病

2012-02-08

科室
- - 订阅+
  - 更多科室
工具
服务